| Size | 100 mL/500 mL |
| Advantages | Kidney cancer organoids precisely replicate the tumor's native environment, facilitating the study of cell growth. They are employed to monitor tumor cell changes during drug exposure and to screen compounds for efficacy and toxicity. |
| Species | Human |
| Components | Basal Medium A; Supplement B, C & D. |
| Research Areas | Drug discovery and toxicity testing; Disease modeling |
| Applications | Organoid culture |
| Storage | Basal Medium A: 4°C, 1 year; Supplement B, C & D: -20°C, 1 year. |
| Shipping Information | Basal Medium A: Shipping with blue ice Supplement B, C & D: Shipping with dry ice. |
| Notes | Refrain from subjecting the product to multiple freeze-thaw cycles. |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.